Identification of a novel dexamethasone-sensitive RNA-destabilizing region on rat monocyte chemoattractant protein 1 mRNA

Molecular and Cellular Biology

Volumn 19, Issue 10, 1999, Pages 6471-6478

  Poon, Michael ^a   Liu, Bin ^a   Taubman, Mark B ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ARTERY MUSCLE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; RAT; RNA ANALYSIS; SMOOTH MUSCLE FIBER;

ANIMALIA;

EID: 0032863156     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.10.6471     Document Type: Article

References (73)

1. Almawi, W. Y., H. N. Beyhum, A. A. Rahme, and M. J. Rieder. 1996. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukoc. Biol. 60:563-572.
2. Amano, Y., S. W. Lee, and A. C. Allison. 1993. Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability. Mol. Pharmacol. 43:176-182.
3. Bachurski, C. J., N. G. Theodorakis, R. M. Coulson, and D. W. Cleveland. 1994. An amino-terminal tetrapeptide specifies cotranslational degradation of beta-tubulin but not alpha-tubulin mRNAs. Mol. Cell. Biol. 14:4076-4086.
4. Barnes, P. J. 1995. Anti-inflammatory mechanisms of glucocorticoids. Biochem. Soc. Trans. 23:940-945.
5. Beato, M. 1989. Gene regulation by steroid hormones. Cell 56:335-344.
6. Bernstein, P. L., D. J. Herrick, R. D. Prokipcak, and J. Ross. 1992. Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant. Genes Dev. 6:642-654.
7. Bogdanov, V. Y., M. Poon, and M. B. Taubman. 1998. PDGF-specific regulation of the JE promoter in rat aortic smooth muscle cells. J. Biol. Chem. 273:24932-24938.
8. Boumpas, D. T., G. P. Chrousos, R. L. Wilder, T. R. Cupps, and J. E. Balow. 1993. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann. Intern. Med. 119:1198-1208.
9. Brewer, G. 1991. An A+U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol. Cell. Biol. 11:2460-2466.
10. Brewer, G., and J. Ross. 1988. Poly(A) shortening and degradation of the 3′ A+U-rich sequences of human c-myc mRNA in a cell-free system. Mol. Cell. Biol. 8:1697-1708.
11. Caput, D., B. Beutler, K. Hartog, R. Thayer, S. Brown-Shimer, and A. Cerami. 1986. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83:1670-1674.
12. Charron, J., and J. Drouin. 1986. Glucocorticoid inhibition of transcription from episomal proopiomelanocortin gene promoter. Proc. Natl. Acad. Sci. USA 83:8903-8907.
13. Chen, C. Y., N. Xu, and A. B. Shyu. 1995. mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation. Mol. Cell. Biol. 15:5777-5788.
14. Chen, C Y., Y. You, and A. B. Shyu. 1992. Two cellular proteins bind specifically to a purine-rich sequence necessary for the destabilization function of a c-fos protein-coding region determinant of mRNA instability. Mol. Cell. Biol. 12:5748-5757.
15. Clinton, S. K., and P. Libby. 1992. Cytokines and growth factors in atherogenesis. Arch. Pathol. Lab. Med. 116:1292-1300.
16. Cochran, H. B., C. A. Reffel, and D. C. Stiles. 1983. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33:939-947.
17. Cushing, S. D., J. A. Berliner, A. J. Valente, M. C. Territo, M. Navab, F. Parhami, R. Gerrity, C. J. Schwartz, and A. M. Fogelman. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA 87:5134-5138.
18. Dompenciel, R. E., V. R. Garnepudi, and D. R. Schoenberg. 1995. Purification and characterization of an estrogen-regulated Xenopus liver polysomal nuclease involved in the selective destabilization of albumin mRNA. J. Biol. Chem. 270:6108-6118.
19. Evans, R. M. 1988. The steroid and thyroid hormone receptor superfamily. Science 240:889-895.
20. Faggiotto, A., R. Ross, and L. Harker. 1984. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 4:323-340.
21. Frisch, S. M., and H. E. Ruley. 1987. Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J. Biol. Chem. 262:16300-16304.
22. Furutani, Y., H. Nomura, M. Notake, Y. Oyamada, F. Toshikazu, M. Yamada, G. C. Larsen, J. J. Oppenheim, and K. Matsushima. 1989. Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). Biochem. Biophys. Res. Commun. 159:249-255.
23. Galis, Z. S., G. K. Sukhova, R. Kranzhofer, S. Clark, and P. Libby. 1995. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc. Natl. Acad. Sci. USA 92:402-406.
24. Gerrity, R. G. 1981. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103:181-190.
25. Harigal, M., M. Hara, T. Yoshimura, E. J. Leonard, K. Inoue, and S. Kashiwazaki. 1993. Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Clin. Immunol. Immunopathol. 69:83-91.
26. Hartner, A., M. Goppelt-Struebe, G. M. Hocke, and R. B. Sterzel. 1997. Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M. Kidney Int. 51:1754-1760.
27. Kawahara, R. S., Z. W. Deng, and T. F. Deuel. 1991. Glucocorticoids inhibit the transcriptional induction of JE, a platelet-derived growth factor-inducible gene. J. Biol. Chem. 266:13261-13266.
28. Klurfeld, D. M. 1985. Identification of foam cells in human atherosclerotic lesions as macrophages using monoclonal antibodies. Arch. Pathol. Lab. Med. 109:445-449.
29. Leonard, E. J., and T. Yoshimura. 1990. Human monocyte chemoattractant protein-1 (MCP-1). Immunol. Today 11:97-101.
30. Libby, P., G. Sukhova, R. T. Lee, and Z. S. Galis. 1995. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J. Cardiovasc. Pharmacol. 25(Suppl 2):S9-S12.
31. Longenecker, J. P., L. A. Kilty, and L. K. Johnson. 1984. Glucocorticoid inhibition of vascular smooth muscle cell proliferation: influence of homologous extracellular matrix and serum mitogens. J. Cell Biol. 98:534-540.
32. Mackman, N. 1995. Regulation of the tissue factor gene. FASEB J. 9:883-889.
33. Maroder, M., S. Martinotti, A. Vacca, I. Screpanti, E. Petrangeli, L. Frati, and A. Gulino. 1990. Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoid hormones in human T lymphoblastic leukemic cells. Nucleic Acids Res. 18:1153-1157.
34. Miyamasu, M., Y. Misaki, S. Izumi, T. Takaishi, Y. Morita, H. Nakamura, K. Matsushima, T. Kasahara, and K. Hirai. 1998. Glucocorticoids inhibit chemokine generation by human eosinophils. J. Allergy Clin. Immunol. 101:75-83.
35. Mordacq, J. C., and D. I. Linzer. 1989. Co-localization of elements required for phorhol ester stimulation and glucocorticoid repression of proliferin gene expression. Genes Dev. 3:760-769.
36. Moskaitis, J. E., S.W. Buzek, R. L. Pastori, and D. R. Schoenberg. 1991. The estrogen-regulated destabilization of Xenopus albumin mRNA is independent of translation. Biochem. Biophys. Res. Commun. 174:825-830.
37. Mukaida, M., C. C. Zachariae, G. L. Gusella, and K. Matsushima. 1991. Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor. J. Immunol. 146:1212-1215.
38. Naito, M., M. Yasue, K. Asai, K. Yamada, T. Hayashi, M. Kuzuya, C. Funaki, N. Yoshimine, and F. Kuzuya. 1992. Effects of dexamethasone on experimental atherosclerosis in cholesterol-fed rabbits. J. Nutr. Sci. Vitaminol. (Tokyo) 38:255-264.
39. Nakano, T., E. W. Raines, J. A. Abraham, F. G. T. Wenzel, S. Higashiyama, M. Klagsbrun, and R. Ross. 1993. Glucocorticoid inhibits thrombin-induced expression of platelet-derived growth factor A-chain and heparin-binding epidermal growth factor-like growth factor in human aortic smooth muscle cells. J. Biol. Chem. 268:22941-22947.
40. Nelken, N. A., S. R. Coughlin, D. Gordon, and J. N. Wilcox. 1991. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Investig. 88:1121-1127.
41. Nichols, N. R., C. A. Olsson, and J. W. Funder. 1983. Steroid effects on protein synthesis in cultured smooth muscle cells from rat aorta. Endocrinology 113:1096-1101.
42. Nikkari, S. T., K. D. O'Brien, M. Ferguson, T. Hatsukami, H. G. Welgus, C. E. Alpers, and A. W. Clowes. 1995. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 92:1393-1398.
43. No, D., T. P. Yao, and R. M. Evans. 1996. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA 93:3346-3351.
44. Nordeen, S. K. 1988. Luciferase reporter gene vectors for analysis of promoters and enhancers. BioTechniques 6:454-458.
45. Paine, R. D., M. W. Rolfe, T. J. Standiford, M. D. Burdick, B. J. Rollins, and R. M. Strieter. 1993. MCP-1 expression by rat type II alveolar epithelial cells in primary culture. J. Immunol. 150:4561-4570.
46. Peltz, S. W., G. Brewer, V. Groppi, and J. Ross. 1989. Exonuclease activity that degrades histone mRNA is stable when DNA or protein synthesis is inhibited. Mol. Biol. Med. 6:227-238.
47. Philippe, J., and M. Missotten. 1990. Dexamethasone inhibits insulin biosynthesis by destabilizing insulin messenger ribonucleic acid in hamster insulinoma cells. Endocrinology 127:1640-1645.
48. Poon, M., S. D. Gertz, J. T. Fallon, P. Wiegman, J. W. Berman, I. J. Sarembock, and M. B. Taubman. Submitted for publication.
49. Poon, M., W. C. Hsu, V. Y. Bogadanov, and M. B. Taubman. 1996. Secretion of monocyte chemotactic activity by cultured rat aortic smooth muscle cells in response to PDGF is due predominantly to the induction of JE/MCP-1. Am. J. Pathol. 149:307-317.
50. Poon, M., J. Megyesi, R. S. Green, H. Zhang, B. J. Rollins, R. Safirstein, and M. B. Taubman. 1991. In vivo and in vitro inhibition of JE gene expression by glucocorticoids. J. Biol. Chem. 266:22375-22379.
51. Reil, T. D., R. Sarkar, V. S. Kashyap, M. Sarkar, and H. A. Gelabert. 1999. Dexamethasone suppresses vascular smooth muscle cell proliferation. J. Surg. Res. 85:109-114.
52. Rivers, A. P. R., E. W. Hathaway, and L. W. Weston. 1975. The endotoxin-induced coagulant activity of human monocytes. Br. J. Haematol. 30:311-316.
53. Rollins, B. J., P. Stier, T. Ernst, and G. G. Wong. 1989. The human homolog of the JE gene encodes a monocyte secretory protein. Mol. Cell. Biol. 9:4687-4695.
54. Rollins, B. J., T. Yoshimura, E. J. Leonard, and J. S. Pober. 1990. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant. MCP-1/JE. Am. J. Pathol. 136:1229-1233.
55. Ross, J. 1995. mRNA stability in mammalian cells. Microbiol. Rev. 59:423-450.
56. Sakai, D. D., S. Helms, J. Carlstedt-Duke, J. A. Gustafsson, F. M. Rottman, and K. R. Yamamoto. 1988. Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev. 2:1144-1154.
57. Sato, K., J. Kuratsu, H. Takeshima, T. Yoshimura, and Y. Ushio. 1995. Expression of monocyte chemoattractant protein-1 in meningioma. J. Neurosurg. 82:874-878.
58. Schuler, G. D., S. F. Altschul, and D. J. Lipman. 1991. A workbench for multiple alignment construction and analysis. Proteins 9:180-190.
59. Stewart, A. G., D. Fernandes, and P. R. Tomlinson. 1995. The effect of glucocorticoids on proliferation of human cultured airway smooth muscle. Br. J. Pharmacol. 116:3219-3226.
60. Strieter, R. M., R. Wiggins, S. H. Phan, B. L. Wharram, H. J. Showell, D. G. Remick, S. W. Chensue, and S. L. Kunkel. 1989. Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. Biochem. Biophys. Res. Commun. 162:694-700.
61. Takeya, M., T. Yoshimura, E. J. Leonard, and K. Takahashi. 1993. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum. Pathol. 24:534-539.
62. Taubman, M. B., J. D. Marmur, C. L. Rosenfield, A. Guha, S. Nichtberger, and Y. Nemerson. 1993. Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. J. Clin. Investig. 91:547-552.
63. Taubman, M. B., B. J. Rollins, M. Poon, J. Marmur, R. S. Green, B. C. Berk, and B. Nadal-Ginard. 1992. JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ. Res. 70:314-325.
64. Thiruvikraman, S. V., A. Guha, J. Roboz, M. B. Taubman, Y. Nemerson, and J. T. Fallon. 1996. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab. Investig. 75:451-461.
65. Tobler, A., R. Meier, M. Seitz, B. Dewald, M. Baggiolini, and M. F. Fey. 1992. Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 79:45-51.
66. Valente, A. J., D. T. Graves, C. E. Vialle-Valentin, R. Delgado, and C. J. Schwartz. 1988. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 27:4162-4168.
67. Wang, X., M. Kiledjian, I. M. Weiss, and S. A. Liebhaber. 1995. Detection and characterization of a 3′ untranslated region ribonucleoprotein complex associated with human alpha-globin mRNA stability. Mol. Cell. Biol. 15: 1769-1777. (Erratum, 15:2331.)
68. Weiner, F. R., M. J. Czaja, D. M. Jefferson, M. A. Giambrone, R. Tur-Kaspa, L. M. Reid, and M. A. Zern. 1987. The effects of dexamethasone on in vitro collagen gene expression. J. Biol. Chem. 262:6955-6958.
69. Yla-Herttuala, S., B. A. Lipton, M. E. Rosenfeld, T. Sarkioja, T. Yoshimura, E. J. Leonard, J. L. Witztum, and D. Steinberg. 1991. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 88:5252-5256.
70. Yoshimura, T., E. A. Robinson, S. Tanaka, E. Appells, J. Kuratsu, and E. J. Leonard. 1989. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J. Exp. Med. 169:1449-1459.
71. Yoshimura, T., N. Yuhki, S. K. Moore, E. Appella, M. I. Lerman, and E. J. Leonard. 1989. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 244:487-493.
72. Yu, X., S. Dluz, D. T. Graves, L. Zhang, H. N. Antoniades, W. Hollander, S. Prusty, A. J. Valente, C. J. Schwartz, and G. E. Sonenshein. 1992. Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc. Natl. Acad. Sci. USA 89: 6953-6957.
73. Zuker, M. 1989. On finding all suboptimal foldings of an RNA molecule. Science 244:48-52.